Clincosm LogoSign in Get a demo

advanced cancer

Showing 76 - 100 of 482
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancer Trial in Houston (Temsirolimus, Bevacizumab, Paclitaxel)

Active, not recruiting
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 11, 2022

Advanced Cancer, Metastatic Cervical Cancer Trial in Albuquerque, Yerevan (Balstilimab (BAL), Topotecan, Vinorelbine)

Withdrawn
  • Advanced Cancer
  • Metastatic Cervical Cancer
  • Balstilimab (BAL)
  • +5 more
  • Albuquerque, New Mexico
  • +2 more
Oct 3, 2022

Lung Cancer, Advanced Cancer Trial in Changsha (Acceptance and Commitment Therapy (ACT), Usual care)

Completed
  • Lung Cancer
  • Advanced Cancer
  • Acceptance and Commitment Therapy (ACT)
  • Usual care
  • Changsha, Hunan, China
    Xiangya Hospital Central South University
Oct 3, 2022

Refractory Cancer, Metastatic Cancer, Recurrent Cancer Trial in Santa Monica (SNK01, Avelumab, Pembrolizumab)

Active, not recruiting
  • Refractory Cancer
  • +6 more
  • SNK01
  • +2 more
  • Santa Monica, California
    Sarcoma Oncology Research Center
Sep 25, 2022

Advanced Cancer Trial in San Diego (personalized vaccine, Pembrolizumab)

Active, not recruiting
  • Advanced Cancer
  • San Diego, California
    UCSD Medical Center
Sep 20, 2022

Advanced Cancer, Angiosarcoma, Colorectal Cancer Without Liver Metastases Trial in United States (Botensilimab, Balstilimab)

Recruiting
  • Advanced Cancer
  • +7 more
  • Scottsdale, Arizona
  • +14 more
Sep 15, 2022

Advanced Cancer, Metastatic Cancer Trial (Q901)

Recruiting
  • Advanced Cancer
  • Metastatic Cancer
  • Phoenix, Arizona
  • +5 more
Sep 1, 2022

Advanced Cancer Trial in Boston (Hospice Video Educational Tool, Standard of Care)

Completed
  • Advanced Cancer
  • Hospice Video Educational Tool
  • Standard of Care
  • Boston, Massachusetts
    Massachusetts general Hospital
Aug 28, 2022

Advanced Cancer Trial in China, United States (ZL-1201)

Active, not recruiting
  • Advanced Cancer
  • Phoenix, Arizona
  • +6 more
Aug 25, 2022

Advanced Cancer, Pleural Effusion Trial in Houston (Intrapleural catheter (IPC) drained, IPC Placement, Chest X-Ray)

Active, not recruiting
  • Advanced Cancer
  • Pleural Effusion
  • Intrapleural catheter (IPC) drained
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 24, 2022

Advanced Cancer Trial in Durham, Greenville (X-PACT)

Recruiting
  • Advanced Cancer
  • X-PACT
  • Durham, North Carolina
  • +1 more
Aug 23, 2022

NSCLC, Advanced Cancer Trial in France (Usual care, Optimization of the medical decision)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Advanced Cancer
  • Usual care
  • Optimization of the medical decision
  • Abbeville, France
  • +24 more
Aug 19, 2022

Advanced Cancer, Melanoma, NSCLC Trial in Worldwide (BMS-986205, Nivolumab, Ipilimumab)

Completed
  • Advanced Cancer
  • +2 more
  • Tucson, Arizona
  • +46 more
Aug 18, 2022

Advanced Cancer Trial in Worldwide (BMS-986148, Nivolumab)

Terminated
Has Results
  • Advanced Cancer
  • La Jolla, California
  • +16 more
Jul 21, 2022

Advanced Cancer, End Stage Organ Failure Trial in United States (Nurse-led telephonic case management, Facilitated,outpatient

Active, not recruiting
  • Advanced Cancer
  • End Stage Organ Failure
  • Nurse-led telephonic case management
  • Facilitated,outpatient specialty palliative care
  • Los Angeles, California
  • +17 more
Aug 16, 2022

Advanced Cancer, Metastatic Cancer, Breast Cancer Trial in United Kingdom, United States (ART4215, Talazoparib, Niraparib)

Recruiting
  • Advanced Cancer
  • +2 more
  • Orlando, Florida
  • +6 more
Aug 16, 2022

Cancer, Solid Tumor, Solid Carcinoma Trial in Houston (AMXT1501, DFMO)

Recruiting
  • Cancer
  • +18 more
  • Houston, Texas
    MD Anderson Cancer Center
Aug 12, 2022

Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma Trial (AMT-151)

Not yet recruiting
  • Advanced Solid Tumor
  • +18 more
  • (no location specified)
Aug 10, 2022

Advanced Cancer, Metastatic Cancer Trial in Spain, United States (FS120)

Recruiting
  • Advanced Cancer
  • Metastatic Cancer
  • New Haven, Connecticut
  • +7 more
Aug 8, 2022

Advanced Cancer, Ovarian Cancer, Lung Cancer Trial in United States (Dose escalation: COM902 monotherapy., Evaluation of

Recruiting
  • Advanced Cancer
  • +6 more
  • Dose escalation: COM902 monotherapy.
  • +3 more
  • Grand Rapids, Michigan
  • +5 more
Aug 8, 2022

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in China, United States (TJ033721)

Recruiting
  • Solid Tumor
  • +6 more
  • Orange, California
  • +17 more
Aug 9, 2022

Advanced Malignancies, Advanced Cancer Trial in United States (ASP7517, Pembrolizumab)

Recruiting
  • Advanced Malignancies
  • Advanced Cancer
  • Atlanta, Georgia
  • +3 more
Aug 2, 2022

Head Neck Cancer, Advanced Cancer, Metastatic Cancer Trial in Bordeaux, Lyon, Nice (Abemaciclib)

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Bordeaux, France
  • +2 more
Jul 22, 2022

Advanced Cancer Trial in Seoul (AST-021p)

Recruiting
  • Advanced Cancer
  • Seoul, Korea, Republic of
  • +2 more
Jul 20, 2022

Metastatic Cancer, Solid Tumor, Advanced Cancer Trial in Korea, Republic of, United States (Evorpacept (ALX148), Pembrolizumab,

Active, not recruiting
  • Metastatic Cancer
  • +3 more
  • Evorpacept (ALX148)
  • +5 more
  • Denver, Colorado
  • +9 more
Jul 20, 2022